pralidoxime and Guillain-Barre-Syndrome

pralidoxime has been researched along with Guillain-Barre-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for pralidoxime and Guillain-Barre-Syndrome

ArticleYear
Guillain-Barre syndrome due to organophosphate compound poison.
    The Journal of the Association of Physicians of India, 2009, Volume: 57

    Acute manifestations of Organophosphate Compound (OPC) poison are due to effect cholinergic excess. Others are intermediate syndrome [IMS], organophosphate induced delayed neuropathy [OPIND] and chronic organophosphate induced neuropsychiatric disorder [COPIND]. All these manifestation have specific period of occurrence and duration. There are very sparse reports of toxic demylination due to OPC poisoning. We report a case of Guillain-Barre Syndrome (GBS) due to toxic demyelination following OPC poison.

    Topics: Adult; Atropine; Chlorpyrifos; Cholinesterase Inhibitors; Cholinesterase Reactivators; Gastric Lavage; Guillain-Barre Syndrome; Humans; Insecticides; Male; Methylprednisolone; Neuroprotective Agents; Parasympatholytics; Plasmapheresis; Pralidoxime Compounds

2009
PAM responsive Gullian Barre like syndrome with low serum cholinesterase.
    The Journal of the Association of Physicians of India, 1998, Volume: 46, Issue:2

    Topics: Cholinesterases; Environmental Exposure; Follow-Up Studies; Guillain-Barre Syndrome; Humans; India; Insecticides; Organophosphorus Compounds; Pralidoxime Compounds; Treatment Outcome

1998